2011
DOI: 10.1590/s1415-47572011005000026
|View full text |Cite
|
Sign up to set email alerts
|

Combination of two rare mutations causes β-thalassaemia in a Bangladeshi patient

Abstract: Screening of mutations that cause β-thalassaemia in the Bangladeshi population led to the identification of a patient with a combination of two rare mutations, Hb Monroe and HBB: −92 C > G. The β-thalassaemia major male individual was transfusion-dependent and had an atypical β-globin gene cluster haplotype. Of the two mutations, Hb Monroe has been characterized in detail. Clinical effects of the other mutation, HBB: −92 C > G, are unknown so far. Bioinformatics analyses were carried out to predict the possibl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 26 publications
0
3
0
1
Order By: Relevance
“…4,5 The mutation can cause hereditary anemias due to decrease hemoglobin synthesis and red blood survival. 6 Beside, structural hemolgobin variant known as hemoglobinophaty are also caused by abnormality in globin chain such as HbS, HbC and HbS.…”
Section: Introductionmentioning
confidence: 99%
“…4,5 The mutation can cause hereditary anemias due to decrease hemoglobin synthesis and red blood survival. 6 Beside, structural hemolgobin variant known as hemoglobinophaty are also caused by abnormality in globin chain such as HbS, HbC and HbS.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the haplotype mutation prevails in the countries situated on the South-western countries of Asian continent. Consequently reports are available from South-East Asian contries including Bangladesh, Myanmar and Thailand (Fattoum et al, 1991; Win et al, 2002; Ibn Ayub et al, 2010; Moosa et al, 2011; Teh et al, 2014; Islam et al, 2018; Srewaradachpisal et al, 2020) (Table 1).…”
Section: Resultsmentioning
confidence: 99%
“…Hb Monroe/Kairouan, впервые идентифицированный в США, позже описан у пациентов в Индии, Бангладеш, Малайзии, ОАЭ, Тунисе, Иране и Таджикистане [13][14][15][16][17][18][19][20][21]. В нашей когорте пациентов Hb Monroe выявлен в 2 неродственных семьях (русские и крымские татары).…”
Section: обсуждение результатов исследованияunclassified